Pharmafile Logo

VJOncology

- PMLiVE

Merck starts pivotal trials of new antibiotic combination

Continues testing after positive phase II results for relebactam addition 

National Institute for Health and Care Excellence NICE logo

NICE backs five new drugs after discounts agreed

Includes Novartis’ previously rejected lung cancer and melanoma therapies Zykadia and Mekinist

- PMLiVE

X4 appoints John Celebi as COO

He joins from Igenica Biotherapeutics

- PMLiVE

Why train… millennials?

Do companies get a return on investment when they train millennials? 

- PMLiVE

BMS appoints Murdo Gordon as chief commercial officer

He also becomes executive vice president

- PMLiVE

UK marketing agency Purple opens Sao Paulo office

New location is the agency’s first in South America

- PMLiVE

Industry welcomes European diagnostics regulations

Trade bodies say they will support greater use of personalised medicines

- PMLiVE

Takeda starts trial of norovirus vaccine

If approved the drug is anticipated to surpass sales of GSK’s Rotarix vaccine

- PMLiVE

Circassia slumps as cat allergy vaccine fails late-stage trial

Has suspended several trials after an “unprecedented” placebo effect derailed leading drug candidate

- PMLiVE

Envigo appoints Patricia Henahan as chief financial officer

She brings experience from AZ, Eli Lilly and Hospira

- PMLiVE

Cost containment and the German market

The healthcare system’s budget limitations will face further pressure from challenges such as personalised medicine

- PMLiVE

Ogilvy & Mather’s ‘Breathless choir’ wins top pharma prize at Lions Health

FCB’s ‘Project literacy’ and DAVID’s ‘Manboobs’ also take home Grand Prix awards

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links